MoonLake Immunotherapeutics (MLTX) offers strong investment potential with key clinical trials and upcoming FDA milestones.

But as the chip maker seeks to parlay its semiconductor dominance into control of the full stack, vendor lock-in is a major risk, says one analyst.

Tom Findling is a strategic leader with a proven track record in go-to-market (GTM), product and data science. Having served as Chief Customer Officer at IntSights (acquired by Rapid7) and ...

From economic development to immigration advocacy, these influential Hispanic leaders are shaping communities while honoring ...

Discover 10 high-paying jobs in such high demand that employers can't hire fast enough. Each one on our list offers salaries ...

In today’s digital age, the opportunity to work from home has expanded significantly, offering lucrative positions across ...

An Emporia State alum returns to campus on Monday for the second session of the Forensic Science Seminar Series.

A recent report by Zhaopin, a major online recruitment platform, showed a surge for three years in a row in the average ...

Preparing students for life after high school graduation has long been a priority for educators within the Medina City School District.

A free account provides you access to a limited number of free articles each month, plus newsletters, job postings, salary ...

LSU EnvironMentors helps high school students learn about STEM through a mentor program with LSU students. Learn more here.